The Fourth International Workshop on Clinical Transplant Tolerance

Area of Science:

• Transplantation immunology
• Clinical trial research

Background:

• Solid organ transplantation often requires long-term immunosuppression.
• Minimizing or withdrawing immunosuppressive drugs is a key goal to improve patient outcomes and reduce toxicity.

Purpose of the Study:

• To review the progress of clinical trials investigating immunosuppression minimization/withdrawal in solid organ transplantation.
• To discuss mechanistic studies and strategies for enhancing tolerance and trial safety.

Main Methods:

• Summary of presentations from the Fourth International Workshop on Clinical Transplant Tolerance.
• Review of ongoing clinical trials in kidney, liver, and lung transplantation.
• Discussion of cell therapy approaches and mechanistic studies.

Main Results:

• Clinical trials are exploring the withdrawal of immunosuppressive drugs post-transplant.
• Protocols often combine organ transplantation with donor or recipient cell therapy.
• Mechanistic studies aim to understand the basis of tolerance and identify biomarkers.

Conclusions:

• Cell therapy combined with organ transplantation is a common strategy in trials aiming for drug withdrawal.
• Further research is needed to understand tolerance mechanisms and identify predictors.
• Improving safety and patient selection for clinical trials remains crucial.